OHSU has created nonhuman primate model for virus that has infected 2 billion worldwide
Charles Rice, a member of the American Association for Advancement of Science, has received a Nobel Prize for the role that he played in discovering Hepatitis C.
Antibiotics may be a good choice for some, but not all, patients with appendicitis, according to results from a large trial that was co-led by UCLA’s Dr. David Talan.
Health, Research, School Of Medicine, Woodruff Health Sciences Center, Clinical Trials, Coronavirus, Health Sciences Research, Infectious Diseases, Vaccines
Johns Hopkins University researchers have found that hospitals could save more lives with a tool that offers earlier identification of patients most at risk of septic shock.
A new report from an international commission of the U.S. National Academy of Medicine, U.S. National Academy of Sciences, and the U.K.’s Royal Society, cautions against permitting editing of the genome of embryos that will be used to produce a pregnancy.
Inspired by blood vessels themselves, researchers in China have created a new "bio-inspired" liquid gating membrane-based catheter out of novel materials that mimic the function and purpose of the vascular system. The catheter could be a game changer in the use, safety and versatility of catheters and other derived applications.
Four pediatric diabetes centers in the country found during a clinical trial that a new artificial pancreas system is safe for children as young as six years old who have type one diabetes.
By using patient discharge data, National Institutes of Health (NIH) funded researchers created a new system for classifying life-threatening complications associated with childbirth in hopes other researches can use what's learned to reduce rising levels of maternal morbidity.
Face masks are a hot topic lately, with the Centers for Disease Control recommending that people wear face masks when outside their homes and when unable to keep a minimum of 6 feet distance between themselves and others to help combat the COVID-19 pandemic.
Cambridge University researchers used a special fluorescent marker to note the location of certain positions of DNA and RNA and found the positions fluctuate between two states, according to a recently released article.
Sarecycline, a drug approved for use in the United States in 2018, is the first new antibiotic approved to treat acne in more than 40 years.
New research into the deadliest form of the malaria, Plasmodium falciparum, shows another set of channels, pore-like holes, in the membrane sac surrounding the parasite that allows it to draw in nutrients from the infected blood cell.
Stanford graduate students published a paper on July 8 detailing a study claiming that Polynesians made contact with Native Americans hundreds of years before the arrival of Europeans.
Movement of proteins to the bacterial cell surface, the environment outside the cell, and even into target cells is critical for bacterial communities and pathogen-host interactions. The export of proteins, from Gram-negative bacteria in particular, is challenging, because two membranes (inner and outer) must be passed.
A “sea squirt” living at the bottom of the ocean may help scientists find a cure for melanoma, the most dangerous type of skin cancer, researchers at the Desert Research Institute in Reno, Nevada, said.
In a Perspective for the New England Journal of Medicine, members of the National Institutes of Health’s Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) Vaccines Working Group assess practical considerations and prerequisites for using controlled human infection models (CHIMs), which can be used for human challenge studies, to support SARS-CoV-2 vaccine development.
A cohort study of individuals from England, Wales and Scotland has revealed a few potential risk factors for individuals who could contract the respiratory condition caused by the novel coronavirus.
Researchers at the Weizmann Institute of Science explored the connections between elements of the microbiome and biomarkers of human traits through a cohort study including populations from Israel and the United States.
The lead researcher, John Ioannidis, of the controversial study of antibodies has responded to his critics who complained about a conflict of interest after David Neeleman was found to have provided funding for the study. An anonymous complaint was filed with Stanford University in early May.